The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/IIa trial of the RNA oligonucleotide STNM01 by EUS-FNI to investigate the safety and efficacy in patients with first-line refractory, unresectable pancreatic cancer.
 
Takayoshi Tsuchiya
Consulting or Advisory Role - Gadelius Medical
Speakers' Bureau - Boston Scientific; Fujifilm; Gadelius Medical; Olympus
 
Toshio Fujisawa
Speakers' Bureau - Boston Scientific; Daiichi Sankyo; Fujifilm; Hitachi; Medico's Hirata; Yakult Honsha
 
Motohiko Kato
Consulting or Advisory Role - Olympus
Speakers' Bureau - AstraZeneca Japan; Olympus; Takeda
 
Masafumi Mizuide
No Relationships to Disclose
 
Yuichi Torisu
No Relationships to Disclose
 
Makoto Nishimura
Honoraria - Boston Scientific; Lumendi; Olympus
Consulting or Advisory Role - Boston Scientific; Lumendi; Olympus
Speakers' Bureau - Olympus; Takeda
Travel, Accommodations, Expenses - Boston Scientific
 
Takashi Kurosawa
No Relationships to Disclose
 
Ko Tomishima
No Relationships to Disclose
 
Kazuki Takakura
No Relationships to Disclose
 
Hiromu Kutsumi
Research Funding - Sekisui Chemical; Toray Industries
 
Yoko Matsuda
No Relationships to Disclose
 
Tomio Arai
No Relationships to Disclose
 
Hideyuki Saya
Consulting or Advisory Role - Robotic Biology Institute
Research Funding - Daiichi-Sankyo Inc.; JSR Corporation; Nobelpharma
 
Shomei Ryozawa
Consulting or Advisory Role - Gadelius Medical
 
Hiroyuki Isayama
Speakers' Bureau - Abbvie; AMCO; Asahi Kasei; Boston Scientific; Century Medical; Cook Medical; Create Medic; Daiichi Sankyo; EA Pharma; Eisai; Fujifilm; Fujifilm; Fujifilm; Gadelius Medical; Gilead Sciences; Hitachi; Japan Lifeline; Kawasumi Laboratories; Medicos Hirata; Mylan; Olympus; Olympus Medical Systems; Otsuka; Piolax; Taiho Pharmaceutical; Yakult Honsha; Zeon Medical
Research Funding - Ajinomoto (Inst); Boston Scientific (Inst); Daiichi Sankyo (Inst); Fujifilm (Inst); Gadelius Medical (Inst); Gilead Sciences (Inst); Hitachi (Inst); Piolax (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst); Zeon Medical (Inst)
 
Takao Itoi
Consulting or Advisory Role - Boston Scientific; Gadelius Medical; Olympus
Speakers' Bureau - Asahi Kasei; Astellas Pharma; Boston Scientific; Daiichi Sankyo; EA Pharma; Fujifilm; Gadelius Medical; Hitachi; Kawasumi Laboratories; Medico's Hirata; Olympus
Research Funding - Boston Scientific (Inst); Fujifilm (Inst); Gadelius Medical (Inst); Kawasumi Laboratories (Inst); Olympus (Inst)
 
Naohisa Yahagi
Honoraria - AstraZeneca; EA Pharma; Olympus; Takeda
Consulting or Advisory Role - Boston Scientific; Olympus; Top Corporation
Research Funding - Kaigen Pharma; Sanwa Kagaku Kenkyusho
Patents, Royalties, Other Intellectual Property - Olympus; Pentax Medical Devices; Top Corporation